Which feature best distinguishes lithium toxicity from therapeutic lithium use in a 32-year-old woman with bipolar disorder maintained on lithium 900 mg daily?

Explanation

## Lithium Toxicity vs. Therapeutic Use: Key Discriminator **Key Point:** The serum lithium concentration and the pattern of neurological signs form the gold standard for distinguishing therapeutic effect from toxicity. Toxicity is characterized by a triad of coarse tremor, confusion, and ataxia when serum levels exceed 2.5 mEq/L. ### Therapeutic Lithium Range - Serum concentration: 0.6–1.2 mEq/L (acute mania) or 0.4–0.8 mEq/L (maintenance) - Side effects: fine tremor, polyuria, polydipsia, mild GI upset, weight gain - These are tolerable and do NOT indicate toxicity ### Lithium Toxicity (Acute) - Serum concentration: >1.5 mEq/L (mild), >2.5 mEq/L (severe) - Neurological triad: **coarse tremor** (not fine), **confusion**, **ataxia** - Additional signs: nausea, vomiting, diarrhea, slurred speech, nystagmus - Renal: polyuria persists but worsens ### Chronic Toxicity - Nephrogenic diabetes insipidus (NDI) - Hypothyroidism - Nephrotic syndrome - These develop over months to years, NOT acutely **High-Yield:** The **coarse tremor + confusion + ataxia + high serum level (>2.5 mEq/L)** is the pathognomonic triad of acute lithium toxicity and is the best discriminator from therapeutic use. **Clinical Pearl:** Fine tremor at therapeutic levels is benign and often improves with dose adjustment or beta-blockers; coarse tremor signals toxicity and requires immediate intervention (hydration, dialysis if severe). **Tip:** In NEET PG, when asked to distinguish therapeutic from toxic, always look for the **serum level + neurological triad** combination. Polyuria and hypothyroidism are chronic effects, not acute discriminators.